TF and cancer: (i)FVIIa–AT levels were higher in cancer patients than in controls.(ii)FVIIa–AT levels were different among the specific types of cancer.(iii)High FVIIa–AT levels were associated with high TF mRNA levels in cancer tissues.(iv)High FVIIa–AT levels were associated with an increased risk of mortality after a 34-month median follow-up.